Search results
Pfizer (NYSE:PFE) Stock Price Down 0.9%
ETF DAILY NEWS· 7 hours agoPfizer Inc. (NYSE:PFE – Get Free Report) was down 0.9% during trading on Thursday . The company traded as low as $27.20 and last traded at $27.41. Approximately 11,513,196 ...
Voisard Asset Management Group Inc. Takes $86,000 Position in Pfizer Inc. (NYSE:PFE)
ETF DAILY NEWS· 6 hours agoThe fund bought 2,998 shares of the biopharmaceutical company’s stock, valued at approximately $86,000. Taylor Financial Group Inc. bought a new stake in Pfizer< ...
Pfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on It
Zacks· 5 days agoDuring this period, the Zacks Large Cap Pharmaceuticals industry, which Pfizer falls in, has gained 5.8%. The key question now is: What could be the stock
Are Dividend Stocks The Best Source Of Passive Income? Here Are Three Alternative Options To...
Benzinga via Yahoo Finance· 1 day agoPassive income is the dream for many investors, providing a steady stream of cash without the need...
Sarepta Jumps After Pfizer's Rival Gene Therapy Flops In Phase 3 Test
Investor's Business Daily· 2 days agoBenefits For Regenxbio, Solid But most analysts didn't consider Pfizer a serious competitor. "The...
Billionaires Are Buying These 2 Ultra-High-Yield Dividend Stocks Hand Over Fist. Are They Smart Buys...
The Motley Fool via AOL· 4 days agoAt recent prices, Pfizer shares offer a 5.9% yield and the confidence that comes with 15 consecutive years of annual dividend raises. Pfizer stock ...
Pfizer (PFE) Stock Declines While Market Improves: Some Information for Investors
Zacks via Yahoo Finance· 3 days agoPfizer (PFE) closed the latest trading day at $27.66, indicating a -1.32% change from the previous...
Pfizer Inc. (NYSE:PFE) Shares Sold by Public Employees Retirement System of Ohio
ETF DAILY NEWS· 1 day agoThe institutional investor owned 2,957,798 shares of the biopharmaceutical company’s stock after selling 54,335 shares during the quarter. Public Employees Retirement System ...
Pfizer’s gene-therapy trial failure boosts Sarepta’s stock
Market Watch· 2 days agogained 4% premarket on Thursday after a potential competitor to its gene therapy stumbled in a...
These 3 Clinical-Stage Biotech Stocks Can Offer Exponential Gains | Investing.com NG
Investing.com· 21 hours agoShares Analysis by The Tokenist (Timothy Fries) covering: Pfizer Inc, Ocuphire Pharma Inc, Rocket...
